Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
First Report of the Prevalence of Human T-Lymphotropic Virus Type 1 (Htlv-1) for Hemodialysis Patients in Tehran Publisher



Yazdani R1 ; Dadmanesh M2 ; Ghorban K3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Immunology, School of Medicine, AJA University of Medical Sciences, Tehran, Iran
  3. 3. Department of Infectious Diseases, School of Medicine, AJA University of Medical Sciences, Tehran, Iran

Source: Archives of Clinical Infectious Diseases Published:2018


Abstract

Background: Human T-lymphotropic virus type 1 (HTLV-1) virus belongs to reterovisuses and is invovled in the etiology of adult T-lymphocytic leukemia (ATL) and tropical spastic paraparesis (TSP). This virus could be transmited through transfusion of contaminated blood or blood products, from the mother to the child or fetus, sexual intercourse, and sharing contaminated syringe needles among addicted individuals. There is no report regarding the prevalance of HTLV-1 among hemodialysis patietns in Tehran. Methods: In this descriptive study, 150 patients, who were under hemodialysis from four military hospitals of Tehran were included. Serum samples were screened to measure the titer of HTLV-1 antibodies by Dia-Pro ELISA kits. Enzyme linked immunosorbent assay (ELISA) positive samples were checked by the western blot method. Results: The results indicated that age of the patients was in the range of 24 to 88 years old and the mean age of patients was 63.58 ± 13.41 years. Among all patients, only one patient (0.66%) had positive anti HTLV-1 ELISA test in the serum while other patients (99.4%) had negative results. The positive sample was confirmed by Western blot analysis. Conclusions: The prevalence rate of HTLV-1 among hemodialysis patients was not high in Tehran. However, it is necessary to take preventive measures to reduce its spread, especially through infectious hemodialysis machines. © 2018, Archives of Clinical Infectious Diseases.
Other Related Docs